Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Imprimis Pharmaceuticals revenue
Imprimis Pharmaceuticals's revenue is $48.9 million.
What is Imprimis Pharmaceuticals's revenue?
- Imprimis Pharmaceuticals's revenue growth from 2019 to 2020 is -4.48%.
- Imprimis Pharmaceuticals has 143 employees, and the revenue per employee ratio is $341,755.
- Imprimis Pharmaceuticals peak revenue was $51.2M in 2019.
- Imprimis Pharmaceuticals annual revenue for 2020 was 48.9M, -4.48% growth from 2019.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Imprimis Pharmaceuticals financial information
| CEO | Mark L. Baum |
| Company Type | Public |
| Employees Number | 143 |
| Date Founded | 1998 |
| Headquarters | San Diego, California |
| Number of Locations | 2 |
| Revenue | $48.9M |
| Net Income | -$3,357,000 |
| Gross Proft | $34.4M (2020) |
| Tax Rate | -0.0% |
| Total Assets | $57,474,000 |
| Ticker | IMMY |
Imprimis Pharmaceuticals jobs you might like
Imprimis Pharmaceuticals financing
Imprimis Pharmaceuticals received early financing of $7.9M on 2012.
| Series | Round size | Date |
|---|---|---|
| Equity | $10M | 2016 |
| Equity | $819K | 2015 |
| Equity | $7.9M | 2012 |
Imprimis Pharmaceuticals investors
| Investors | Security type |
|---|---|
| SWK Funding | Post-IPO Debt - Imprimis Pharmaceuticals |
| Life Sciences Alternative Funding | Debt Financing - Imprimis Pharmaceuticals |
Imprimis Pharmaceuticals competitors
Imprimis Pharmaceuticals's top competitor, Merck, earned an annual revenue of $64.2B.
Imprimis Pharmaceuticals's smallest competitor is Affinity Health with revenue of $4.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Merck | $90,328 | $64.2B | 74,000 | 1,400 |
| Medivation | $94,135 | $1.0B | 628 | - |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 832 |
| Forest Laboratories | $91,901 | $3.6B | 6,200 | - |
| Upsher-Smith Laboratories | $63,937 | $420.0M | 550 | 26 |
| Emergent BioSolutions | $77,521 | $1.6B | 1,834 | 4 |
| Human Genome Sciences | $70,157 | $131.0M | 1,000 | - |
| Acorda Therapeutics | $97,279 | $117.6M | 344 | - |
| CuraScript SD | $46,601 | $18.0M | 378 | - |
| Davita Rx | $43,672 | $34.9M | 291 | - |
Imprimis Pharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Imprimis Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Imprimis Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Imprimis Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Imprimis Pharmaceuticals. The data presented on this page does not represent the view of Imprimis Pharmaceuticals and its employees or that of Zippia.
Imprimis Pharmaceuticals may also be known as or be related to Imprimis Pharmaceuticals, Imprimis Pharmaceuticals Inc and Imprimis Pharmaceuticals, Inc.